CTLA4 and neoplasm: Furthermore, the expression of CTLA-4 in the sorted T cells increases slightly in the CAP-treated group, in a manner similar to the expression of its ligand, CD80, in the tumor cells; however, the difference is not significant (Figure 5a,b).